Skip to main content

Table 3 Hazard of unfavorable treatment outcome at the end of follow-up among those active in HAART care at months 6, 12, 18 and 24 months

From: Patients who restart antiretroviral medication after interruption remain at high risk of unfavorable outcomes in Ethiopia

Variable

Sub-category

Hazard ratio, adj

P-value

Ever discontinued HAART before 6 months

No

1

 

Yes

1.9

0.003

Ever discontinued HAART before 12 months

No

1

 

Yes

2.4

<0.001

Ever discontinued HAART before 18 months

No

1

 

Yes

2.6

<0.001

Ever discontinued ART before 24 months

No

1

 

Yes

2.4

<0.001

Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us